Detalles de la búsqueda
1.
Efficacy and tolerability of bevacizumab in patients with severe Covid-19.
Nat Commun
; 12(1): 814, 2021 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547300
2.
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies.
Breast Care (Basel)
; 15(1): 30-37, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32231495
3.
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(94): 36720-36721, 2018 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30613355
4.
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(77): 34639-34640, 2018 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30349655
5.
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(61): 31877-31887, 2018 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30159129
Resultados
1 -
5
de 5
1
Próxima >
>>